187 studies found for:    "Parkes Weber syndrome" OR "Vascular Malformations"
Show Display Options
Rank Status Study
21 Recruiting Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
Conditions: Brain Injury;   Central Nervous System Degenerative Disorder;   Central Nervous System Infectious Disorder;   Central Nervous System Vascular Malformation;   Hemorrhagic Cerebrovascular Accident;   Ischemic Cerebrovascular Accident;   Primary Brain Neoplasm;   Brain Cancer;   Brain Tumors
Interventions: Drug: Ferumoxytol;   Other: Tissue Analysis;   Procedure: Magnetic Resonance Imaging
22 Recruiting AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)
Conditions: Turner Syndrome;   Peripheral Angiopathy;   Vascular Malformation;   Lymphedema
Intervention: Procedure: Echo doppler
23 Active, not recruiting Bone Health in Patients With Overgrowth
Conditions: Bone Mineral Density;   Vascular Malformations
Intervention:
24 Recruiting Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Small Bowel Angiodysplasias
Conditions: Angiodysplasia;   Vascular Malformations;   Gastrointestinal Hemorrhage;   Anemia
Intervention: Drug: Octreotide
25 Enrolling by invitation The Management of Postoperative Craniotomy Pain in Pediatric Patients
Conditions: Post Craniotomy Surgery;   Cancer;   Epilepsy;   Vascular Malformations;   Craniofacial Reconstructive Surgery
Intervention:
26 Recruiting Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Condition: Cardiovascular Abnormalities
Intervention: Drug: Sirolimus
27 Completed Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
28 Active, not recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
29 Recruiting Lymphatic Anomalies Registry
Conditions: Lymphatic Malformation;   Generalized Lymphatic Anomaly (GLA);   Central Conducting Lymphatic Anomaly;   CLOVES Syndrome;   Gorham-Stout Disease ("Disappearing Bone Disease");   Blue Rubber Bleb Nevus Syndrome;   Kaposiform Lymphangiomatosis;   Kaposiform Hemangioendothelioma/Tufted Angioma;   Klippel-Trenaunay Syndrome;   Lymphangiomatosis
Intervention:
30 Completed Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Condition: Vascular Anomalies
Intervention: Drug: Marimastat
31 Active, not recruiting ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae
Condition: Arteriovenous Fistula
Intervention:
32 Recruiting Treatment of Brain AVMs (TOBAS) Study
Conditions: Unruptured Brain Arteriovenous Malformation;   Ruptured Brain Arteriovenous Malformation;   Arteriovenous Malformations;   AVM;   BAVM
Interventions: Procedure: Neurosurgery;   Radiation: Radiation therapy;   Procedure: Embolization
33 Recruiting Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Condition: Hereditary Hemorrhagic Telangiectasia (HHT).
Interventions: Drug: Topical timolol maleate;   Drug: placebo saline drops
34 Completed Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia
Interventions: Drug: Tranexamic acid first, than placebo;   Drug: First placebo, than Tranexamic acid.
35 Withdrawn Effect of Laser Treatment on Capillary Malformations
Conditions: Capillary Malformation;   Port Wine Stain
Intervention:
36 Unknown  Assessing the Effects of Air-cooling on Capillary Malformations
Conditions: Capillary Malformation;   Laser;   Skin Cooling
Intervention: Device: Air cooling to CM site
37 Not yet recruiting Atorvastatin Therapy in Cerebral Cavernous Malformation: A Proof of Concept Phase I/II Trial
Condition: Cerebral Cavernous Malformation
Interventions: Drug: Atorvastatin;   Other: Placebo
38 Recruiting Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic Agent
Condition: Cerebral Arteriovenous Malformations
Intervention: Device: SQUID™
39 Completed Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations
Condition: Intracranial Arteriovenous Malformations (AVM)
Interventions: Procedure: Fractionated stereotactic radiosurgery;   Device: Leskell gamma unit
40 Recruiting ONYX Evaluation in the Endovascular Treatment of Cerebral Arteriovenous Malformations (cAVM)
Condition: Cerebral Arteriovenous Malformations
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years